Developing Innovative Intervention Approaches for Methamphetamine-Using Men who have Sex with Men Not Currently in Drug Treatment§ by Mansergh, Gordon et al.
Editorial  The Open AIDS Journal, 2010, Volume 4    103 
 
  1874-6136/10  2010 Bentham Open 
Open Access 
Editorial 
Developing Innovative Intervention Approaches for Methamphetamine-
Using Men who have Sex with Men Not Currently in Drug Treatment
§ 
Gordon Mansergh, Mahnaz R. Charania and David Purcell 
Men who have sex with men (MSM) continue to be disproportionately affected by HIV and AIDS. The U.S. Centers for 
Disease Control and Prevention (CDC) estimates that MSM account for 48% of all men living with HIV and 53% of all new 
HIV infections in the United States in 2007 [1], and the number of incident cases among MSM continue to increase in the U.S. 
while incidence has been flat or declining for other risk groups [2]. Further, MSM are at elevated risk for HIV infection 
throughout the world [3]. 
Several U.S. studies [4-6] suggest that unprotected anal sex accounts for the acquisition of most HIV infections among MSM, 
and situational factors play an important role in understanding sexual
  risk taking. One such factor is the use of 
methamphetamine during sex. Methamphetamine, a central nervous system stimulant, has been consistently linked to 
unprotected anal sex among MSM [7] as well as to acquisition of HIV [8]. Methamphetamine use has distinct, long lasting 
cognitive effects that can lead to sexual disinhibition and impaired judgment, and is often associated with poor adherence to 
medication regimens [9-11]. Methamphetamine-using MSM are up to 4 times more likely to engage in unprotected anal sex, 
compared to substance-using MSM who do not use methamphetamine [10]. 
In a longitudinal study of more than 4000 HIV-negative MSM, Koblin and her colleagues found that prospectively, 
methamphetamine was an independent risk factor for HIV seroconversion [8]. HIV-positive MSM who use methamphetamine 
(compared to MSM who do not) are also more susceptible to acquiring other STDs and possibly infecting their sexual partners 
because methamphetamine also functions as an immunosuppressive drug that decreases CD4 levels while increasing viral load 
[12]. 
Although several reviews and summaries have highlighted the efficacy of HIV behavioral interventions for MSM [13-15], CDC 
has only identified a small number of evidence-based interventions for MSM that reduce sexual risk behavior and none target 
substance-using men [16]. Behavioral HIV prevention may be particularly challenging for substance-using MSM due to 
competing physical and emotional needs [17], as well as direct and indirect effects of methamphetamine use. Prior studies have 
reported on a successful intensive drug treatment model for methamphetamine users to reduce drug use and related harms [18]. 
In addition, a study of methamphetamine-using MSM found four different treatment-based approaches that successfully 
reduced sexual risk behavior and methamphetamine use from baseline, but there were no difference between groups in sexual 
risk reduction [19]. Thus, there remains a need for researchers to develop, implement, and evaluate the efficacy of behavioral 
HIV prevention interventions for substance-using MSM. 
In 2006, the CDC Division of HIV/AIDS Prevention announced a scientific initiative to fund formative research and pilot 
testing of four interventions for methamphetamine-using MSM not currently in drug treatment (CDC PS06-007). This was 
partly in response to research recommendations from a CDC national consultation on methamphetamine use and risk for HIV 
and STD transmission [7]. The goal was to demonstrate, through pilot testing, promising interventions for reducing risk for 
HIV acquisition and transmission. This approach would allow for relatively rapid development, design, and preliminary testing 
of multiple approaches simultaneously. It was intended that the research program would identify the most promising 
approaches. Then, these interventions may be further tested with more costly randomized-control trials that would be separately 
funded by federal or non-federal funders. Four of the following five papers presented here represent interventions that were 
funded through this funding announcement; the fifth paper represents a seed grant partially funded by CDC. 
This special issue is devoted specifically to the development and design of interventions for methamphetamine-using MSM 
who were not currently in drug treatment. As such, the papers focus on innovative formative research, intervention design, and 
preliminary testing intended to evaluate the feasibility and acceptability of the interventions for the target population, as well as 
pilot testing of interventions. The papers presented here are not intended to provide behavioral outcome assessments, but to 
focus on critical developmental work that is often not thoroughly described. We hope to underscore the importance of 
balancing theoretical and practical issues when designing and testing interventions for such high-risk populations. 
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